Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.71 |
| ▸ | CHRNA7 | P36544 | 5/20 | 0.70 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.67 |
| ▸ | CTSL | P07711 | 1/20 | 0.67 |
| ▸ | CTSB | P07858 | 1/20 | 0.67 |
| ▸ | TYR | P14679 | 1/20 | 0.66 |
| ▸ | MAOB | P27338 | 3/20 | 0.65 |
| ▸ | P4HB | P07237 | 1/20 | 0.65 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.65 |
| ▸ | F3 | P13726 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.64 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.64 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.64 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.64 |
| ▸ | MAOA | P21397 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9250766 | 1.00 | MAPT (0.76) | MAPTMAPK1KMT2AMEN1HSP90AA1 | |
| SCHEMBL10893208 | 0.89 | MAPT (0.75) | MAPTMAPK1KMT2AMEN1HSP90AA1 | |
| SCHEMBL626785 | 0.89 | MAPT (0.75) | MAPTMAPK1KMT2AMEN1HSP90AA1 | |
| SCHEMBL626787 | 0.89 | MAPT (0.75) | MAPTMAPK1KMT2AMEN1HSP90AA1 | |
| SCHEMBL29420130 | 0.89 | MAPT (0.75) | MAPTMAPK1KMT2AMEN1HSP90AA1 | |
| Methane SCHEMBL728022 | 0.87 | MAPT (0.73) | MAPTMAPK1KMT2AMEN1HSP90AA1 | |
| SCHEMBL5084329 | 0.86 | MAPT (0.71) | MAPTMAPK1KMT2AMEN1HSP90AA1 | |
| SCHEMBL21647113 | 0.86 | MAPT (0.71) | MAPTMAPK1KMT2AMEN1HSP90AA1 | |
| SCHEMBL21647129 | 0.86 | MAPT (0.71) | MAPTMAPK1KMT2AMEN1HSP90AA1 | |
| SCHEMBL21647128 | 0.86 | MAPT (0.71) | MAPTMAPK1KMT2AMEN1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4496476-A1 | GAS PHASE TREATMENT OF PRODUCE | Apeel Technology, Inc. (US) | 2025-01-29 | — | — | EP | claimed |
| CN-117320559-A | Edible coating with antimicrobial properties | 阿比尔技术公司 | 2023-12-29 | — | — | CN | claimed |
| WO-2023183341-A1 | GAS PHASE TREATMENT OF PRODUCE | APEEL TECHNOLOGY, INC. (US) | 2023-09-28 | — | — | WO | claimed |
| CN-116783722-A | Electrochemical cell, assembly thereof and method of making same | 阿尔西姆能源公司 | 2023-09-19 | — | — | CN | claimed |
| EP-4211732-A1 | ELECTROCHEMICAL CELLS, COMPONENTS THEREOF, AND METHODS OF THEIR MANUFACTURE | Alsym Energy, Inc. (US) | 2023-07-19 | — | — | EP | claimed |
| US-20220330565-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECHNOLOGY, INC. | 2022-10-20 | — | — | US | claimed |
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20250204541-A1 | GAS PHASE TREATMENT OF PRODUCE | APEEL TECHNOLOGY, INC. | 2025-06-26 | — | — | US | disclosed |
| US-20240156117-A1 | EDIBLE COATING COMPOSITIONS | APEEL TECH INC (US) | 2024-05-16 | — | — | US | disclosed |
| CN-117769354-A | Barrier film composition | 阿比尔技术公司 | 2024-03-26 | — | — | CN | disclosed |
| EP-4312533-A1 | BARRIER FILM COMPOSITION | Apeel Technology, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| US-20240008501-A1 | EDIBLE COATING COMPOSITIONS | APEEL TECHNOLOGY, INC. | 2024-01-11 | — | — | US | disclosed |
| US-20220312784-A1 | BARRIER FILM COMPOSITION | APEEL TECHNOLOGY, INC. | 2022-10-06 | — | — | US | disclosed |
| US-20160008298-A1 | XANTHOHUMOL-BASED COMPOUNDS AND COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME | OREGON STATE UNIVERSITY | 2016-01-14 | — | — | US | disclosed |
| US-20140135359-A1 | METHODS OF DESIGNING, PREPARING, AND USING NOVEL PROTONOPHORES | MARTINEAU LOUIS C (CA) | 2014-05-15 | — | — | US | disclosed |
| WO-2007084721-A2 | SKIN PROTECTION AND MOISTURIZING COMPOSITIONS AND METHODS | SAKURA PROPERTIES, LLC (US) | 2007-07-26 | — | — | WO | disclosed |
| EP-0370461-B1 | Chalcone derivatives and process for producing the same | DAINIPPON INK & CHEMICALS (JP) | 1995-06-28 | — | — | EP | disclosed |
| US-5068364-A | Antiulcer agents, antiallergens | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1991-11-26 | — | — | US | disclosed |
| EP-0370461-A2 | Chalcone derivatives and process for producing the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1990-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140135359-A1 | METHODS OF DESIGNING, PREPARING, AND USING NOVEL PROTONOPHORES | UQCRC2, UQCRC1, TIMM50 | MAPT 4702/4885MAPK1 3792/4885KMT2A 3551/4885 |
| US-20160008298-A1 | XANTHOHUMOL-BASED COMPOUNDS AND COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME | GPR119, PC, CS | MAPT 2717/4885MAPK1 2679/4885KMT2A 2959/4885 |
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | CYP51A1, ERG28, NISCH | MAPT 4702/4885MAPK1 673/4885KMT2A 1152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.